Goodwill is tested for impairment at a reporting unit level on at least an annual basis, in accordance with the subsequent measurement provisions of the accounting guidance for goodwill. Consistent with prior years, the Company performed its annual impairment test in the third quarter, specifically as of July 31, 2019. The Company changed its management structure during the third quarter to combine its two historical operating segments into a single unified physician services operating segment. However, for goodwill testing purposes, the Company determined that its reporting units would be represented by the components that underly the unified physician services operating segment. The reporting units represent the service line medical groups of Women’s and Children’s, anesthesiology and radiology.

The Company used a combination of income and market-based valuation approaches to determine the fair value of its reporting units

ased on the analysis performed

the Company recorded a

non-cash

impairment charge of $1.30 billion during the three months ended September 30,

2019, nearly all of which related

to its

nesthesiology reporting unit.

Recognition of the non-cash charge against goodwill resulted in a tax benefit which generated an additional deferred tax asset

$147.2 million

that increased the fair value of the reporting units. An incremental non-cash charge is then required to reduce the reporting units to their previously determined fair value. Accordingly, the Company recorded the incremental non-cash charge of $147.2 million for a total non-cash charge of $1.45 billion.

The primary factors driving the

non-cash

impairment charge were

(i) the change in management structure effective during the third quarter resulting in reporting units one level below the Company’s single physician services operating segment, which is also its single reportable segment,

(ii

) the decrease in the Company’s share price used in the market capitalization reconciliation and

(iii

) changes in the assumptions used in the valuation analysis, specifically the discount rate used in the cash flow analysis

which included a company

specific risk premium

The Company’s goodwill balance

after the non-cash impairment charge

at September 30, 2019 was $2.63 billion.